TRIAL OÜ is a OÜ based in Tallinn, registry code 12170339, status: in liquidation. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q2 2026 was €0 with employees.
Turnover
0 €
↓ 100.0%vs Q1 2026
State taxes
—
Labour taxes
—
Employees
—
Q2 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry Scientific research and development · EMTAK 72
Revenue · 20253 110 €
above 61% of companies
industry median 0 € · companies in the industry: 1 073
Net profit margin · 202536.2 %
above 63% of companies
industry median 13.5 % · companies in the industry: 597
Taxes and turnover
Q3 2023 – Q2 2026
Turnover, € Q2 2026: 0 € · −100.0% vs Q1 2026 · industry median 14 545 € · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Labour taxes per employee, € Q4 2025: 140 € · +122.2% vs Q3 2025 · industry median 2 069 € · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
EmployeesQ4 2025: 1 · +0.0% vs Q3 2025State taxes, € Q1 2026: 0 € · −100.0% vs Q4 2025
Figures by quarter
Quarter
Turnover, €
State taxes, €
Labour taxes, €
Employees
Q2 2026
—
—
—
—
Q1 2026
200
—
—
—
Q4 2025
2 302
138
140
1
Q3 2025
304
62
63
1
Q2 2025
304
62
63
1
Q1 2025
152
—
—
1
Q4 2024
152
120
122
1
Q3 2024
304
—
—
1
Q2 2024
304
—
—
1
Q1 2024
608
180
182
1
Q4 2023
—
—
—
1
Q3 2023
152
—
—
1
Q2 2023
152
—
—
1
Q1 2023
304
60
61
1
Q4 2022
304
60
61
1
Q3 2022
824
60
61
1
Q2 2022
304
60
61
1
Q1 2022
152
54
55
1
Financials by year
2017 – 2026
Revenue, € 2025: 3 110 € · +241.0% vs 2024 · industry median 0 € · above 61% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit, € 2025: 1 127 € · +28 075.0% vs 2024 · industry median 0 € · above 65% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit margin, % 2025: 36.2 % · industry median 13.5 % · above 63% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Assets, € 2025: 3 634 € · +45.0% vs 2024Equity, € 2025: 3 634 € · +45.0% vs 2024Employees2026: 0
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Financials by year
Year
Revenue, €
Net profit, €
Labour costs, €
Assets, €
Equity, €
Employees
2026
—
—
—
—
—
0
2025
3 110
1 127
638
3 634
3 634
0
2024
912
4
302
2 507
2 507
0
2023
912
3
605
2 829
2 503
0
2022
1 888
-1 576
590
2 500
2 500
0
2021
3 824
1 515
1 091
4 076
4 076
0
2020
0
-111
0
2 762
2 562
0
2019
4 249
-24 666
870
2 685
2 673
0
2018
—
—
—
—
—
1
2017
—
—
—
—
—
1
2016
—
—
—
—
—
1
2015
—
—
—
—
—
1
2014
—
—
—
—
—
1
2013
—
—
—
—
—
1
2012
—
—
—
—
—
1
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.